Imeron (Iomeprol)

Imeron (iomeprol) is an iodinated contrast agent used to improve X‑ray based imaging across several diagnostic procedures, delivering superior contrast enhancement and facilitating accurate clinical interpretation.

• Contrast‑enhanced computed tomography: provides high‑contrast images of vascular and organ structures, aiding diagnosis.
• Angiography: delineates blood vessels with enhanced radiopacity for accurate assessment and interventional planning.
• Urography: enhances visualization of the urinary tract, facilitating detection of obstructions or lesions.
• Venography: improves detection of venous pathology by increasing contrast between veins and surrounding tissues.

• After intravenous injection, iomeprol distributes rapidly within the extracellular fluid and vascular compartments. The molecule contains a high density of iodine atoms, each of which strongly absorbs X‑ray photons. This increased attenuation creates a radiopaque effect, making blood‑filled structures appear brighter on X‑ray, CT or fluoroscopic images. As a non‑ionic, low‑osmolality agent, iomeprol minimizes protein binding and reduces the risk of osmotic‑related adverse reactions while providing consistent image contrast.

Imeron may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects

• Warm sensation or flushing: transient feeling of heat or skin reddening.
• Nausea or vomiting: mild gastrointestinal upset occurring shortly after injection.
• Headache: temporary discomfort that usually resolves without treatment.
• Mild urticaria or itching: limited skin rash that subsides spontaneously.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response that can include airway obstruction and shock.
• Acute renal impairment: sudden decrease in kidney function, particularly in at‑risk patients.
• Cardiovascular collapse: profound hypotension or arrhythmia requiring immediate medical intervention.

Before using Imeron, clinicians should observe several precautionary measures to reduce the risk of adverse events.

• Assess renal function: evaluate serum creatinine and eGFR to determine suitability.
• Review iodine allergy history: identify prior reactions to iodinated contrast media.
• Ensure adequate hydration: encourage fluid intake before and after the procedure.
• Use the lowest effective dose: tailor volume to the specific imaging study.
• Monitor vital signs: observe blood pressure and heart rate during and after injection.
• Store at ambient temperature: keep vials in original packaging, protect from light and moisture, and do not freeze.

Imeron can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid)

• Cumulative iodine load: avoid concurrent use of other iodinated contrast agents.
• Metformin in renal impairment: risk of lactic acidosis; consider temporary discontinuation.
• Nephrotoxic drugs: concurrent aminoglycosides, NSAIDs or radiopharmaceuticals may increase kidney injury risk.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask tachycardia signs of contrast reaction.
• Diuretics: can affect fluid balance and enhance renal stress.
• Thyroid hormone therapy: excess iodine may alter thyroid function tests.